At-home administration was safe, effective, and had higher participant satisfaction. Why vaccine hesitancy is rising—and what we can do to counter it with facts, trust, and access. There have been 12 outbreaks in 2025 so far, defined as three or more related cases. The NoiseFilter team expresses deep concern over policy changes to vaccine strategy following RFK Jr's appointment. The group delves into a discussion on how measles is not only a national concern but also an international danger. MarkAlain Dery, DO, breaks down the pathogenesis of measles, how it presents, why it is so misunderstood, and much more. The universal coronavirus vaccine targets the low-mutation stalk region of the virus. Christian Olsen, VP of Dotmatics, describes how COVID-19 forever altered drug development timelines. Understanding the signs and symptoms of hantavirus, the infection the claimed the life of Gene Hackman's wife. The model takes into consideration that different social factors present different types of access barriers. An increase in intestinal permeability allows gut bacteria to reach bone marrow. A study compared the screening performances of a tools used in cervical cancer screening in HIV-positive women. Targeted discovery proteomics and transcriptomics approaches were used. Dr. Shaun Grannis talks about a large-scale study which showed the robust efficacy of RSV vaccine in older adults. A cross-sectional study aimed to assess RSV rates before the 2023 vaccine introduction. The recent increase in extreme weather events is increasing both waterborne and mosquito-borne infections. The index date marked the start of the respiratory episode that involved hospitalization or a diagnosis of RSV or flu. Researchers compared four RSV seasons, two before and two during the COVID-19 pandemic. Preliminary data highlight the potential of rAAV5 vectors in RSV immunity. Public worry about contracting RSV has appreciably dropped in the past year, though not worry about COVID-19 or seasonal flu.